1Hu KQ, Yu AS, Tiyyagura L, et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit [ J]. Am J Gast roenterol, 2001, 96 (5) : 1586.
3Carr JM. Disseminated intravascular coagulation in cirrhosis. Hepatology,1989,10∶103-110.
4Mombelli G, Fiori G, Monotti R, et al. Fibrinopeptide A in liver cirrhosis:evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease. J Lab Clin Med, 1993,121∶83-90.
5Hao Jinghua, Shi Jun, Ren Wanhua, et al. Hepatic microcirculatory disturbances in patients with hepatitis B. Chinese Med J, 2002,115∶65-68.
7McEver RP, Bechstead JH, Moore KL, et al. GMP-140, a platelet-granule membrane protein, is also synthesized by vascular endothelial cell and is localized in Weibel-Palade bodies. J Clin Invest, 1989,84∶92-99.
8Sadler JE. Von Willebrand Factor. J Biol Chem, 1991,266∶22777-22780.
9Kruskal RJ, Seitz D, Notan CR, et al. Elevated fibrin-related and fibrinogen related antigens in patients with liver disease. Hepatology, 1992,16∶920-922.
10Violi F, Ferro D, Basili S, et al. Associated between low-grade disseminated intravascular coagulation and endotoximia in patients with liver cirrhosis. Gastroenterology, 1995,109∶531-539.
